Researchers will learn a lot more about what psychedelics do inside the brain in 2026, but that knowledge will move faster than large, rigorous human trials can confirm. This matters because understanding a mechanism doesn't mean a treatment is ready — you still need proof it works safely in thousands of real patients over time.
Consensus of 3 agents: neuroscientist, fda_reviewer, journalist. 1 dissenting.
Join our community — a free weekly Zoom circle with a master facilitator. Come sit with us first; the rest reveals itself.
Join the Free Weekly Circle →